These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 529025)

  • 1. A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.
    Gaillot J; Steimer JL; Mallet AJ; Thebault JJ; Bieder A
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):579-628. PubMed ID: 529025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach.
    Taright N; Mentré F; Mallet A; Jouvent R
    Ther Drug Monit; 1994 Jun; 16(3):258-69. PubMed ID: 8085280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal clearance technic for individualizing lithium dosage in routine hospital care].
    Klinger E; Steimer JL; Jouvent R; Le Moël G; Mascart JY; Des Lauriers A
    Encephale; 1984; 10(5):223-30. PubMed ID: 6440774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Nomiyama N; Higuchi S; Aoyama T
    Ther Drug Monit; 1993 Apr; 15(2):75-82. PubMed ID: 8503142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
    Marr MA; Djuric PE; Ritschel WA; Garver DL
    Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
    Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM
    Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level monitoring and clinical pharmacokinetics of lithium.
    Amdisen A
    Clin Pharmacokinet; 1977; 2(2):73-92. PubMed ID: 324690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of lithium in the elderly.
    Hardy BG; Shulman KI; Mackenzie SE; Kutcher SP; Silverberg JD
    J Clin Psychopharmacol; 1987 Jun; 7(3):153-8. PubMed ID: 3110219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium dosage regimen design by the repeated one-point method.
    Ritschel WA; Banarer M
    Arzneimittelforschung; 1982; 32(2):98-102. PubMed ID: 7199926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between standardized twelve-hour serum lithium, mean serum lithium of the 24-hour day, dose regimen, and therapeutic interval. An evaluation based on pharmacokinetic simulations.
    Amdisen A; Nielsen-Kudsk F
    Pharmacopsychiatry; 1986 Nov; 19(6):416-9. PubMed ID: 3797468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lithium balance in healthy volunteers].
    Consbruch U; Degkwitz R; Koufen H
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):228-34. PubMed ID: 704664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder.
    Jin ZB; Wu Z; Cui YF; Liu XP; Liang HB; You JY; Wang CY
    Front Pharmacol; 2022; 13():913935. PubMed ID: 35860024
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens.
    Schou M; Amdisen A; Thomsen K; Vestergaard P; Hetmar O; Mellerup ET; Plenge P; Rafaelsen OJ
    Psychopharmacology (Berl); 1982; 77(4):387-90. PubMed ID: 6813903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients.
    Abou-Auda HS; Al-Yamani MJ; Abou-Shaaban RR; Khoshhal SI
    Bipolar Disord; 2008 May; 10(3):369-76. PubMed ID: 18402625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis.
    Weir S; Gao Y; Henney HR
    Curr Med Res Opin; 2013 Dec; 29(12):1637-45. PubMed ID: 23157466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three a priori methods and one empirical method in predicting lithium dosage requirements.
    Wright R; Crismon ML
    Am J Health Syst Pharm; 2000 Sep; 57(18):1698-702. PubMed ID: 11006797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.